Who has invested in ImmVirX?

One Ventures, Acorn Capital are named among the investors backing ImmVirX.

ImmVirX Funding: $47M Raised, Series B (2023)

ImmVirX funding overview

ImmVirX is based in New Lambton Heights, Nsw, Australia. ImmVirX has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2023. The round record for ImmVirX runs through 2023; nothing later has been disclosed. Investors on record include One Ventures, Acorn Capital. 2 distinct backers are named across the disclosed rounds.

ImmVirX at a glance

Total raised: $47M
Latest round: Series B
Latest round date: June 2023
Headquarters: New Lambton Heights, Nsw, Australia
Notable investors: One Ventures, Acorn Capital

Frequently asked about ImmVirX funding

How much has ImmVirX raised?: ImmVirX has raised $47M in total disclosed funding across the rounds on record.
Who has invested in ImmVirX?: One Ventures, Acorn Capital are named among the investors backing ImmVirX.
What was the latest ImmVirX funding round?: The most recent disclosed round is a Series B, announced in June 2023.
Where is ImmVirX based?: ImmVirX is based in New Lambton Heights, Nsw, Australia.
When did ImmVirX last raise?: The last disclosed ImmVirX round closed in June 2023 at Series B.

Totals shown for ImmVirX aggregate every disclosed round on file. To see how that compares, browse the companies in New Lambton Heights and the investors behind them below.

ImmVirX Funding: $47M Raised, Series B (2023)

ImmVirX funding overview

ImmVirX at a glance

Frequently asked about ImmVirX funding

Companies related to ImmVirX (30)

Browse related funding lists (3)